Similarly, modified SZ can increase tyrosine-phosphorylated insulin receptor substrate-1 (IRS-1) in the skeletal muscle of T2DM rats to relieve insulin resistance [15]. The gene discussed is IRS1; the disease is type 2 diabetes mellitus.